242 related articles for article (PubMed ID: 23389114)
1. Sulforaphane inhibits growth of phenotypically different breast cancer cells.
Pawlik A; Wiczk A; Kaczyńska A; Antosiewicz J; Herman-Antosiewicz A
Eur J Nutr; 2013 Dec; 52(8):1949-58. PubMed ID: 23389114
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of HER2 Positive Breast Cancer Cells to Lapatinib Using Plants-Derived Isothiocyanates.
Kaczyńska A; Świerczyńska J; Herman-Antosiewicz A
Nutr Cancer; 2015; 67(6):976-86. PubMed ID: 26134366
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.
He X; Wang Y; Zhu J; Orloff M; Eng C
Cancer Lett; 2011 Feb; 301(2):168-76. PubMed ID: 21168265
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway.
Jiang J; Yang Y; Wang F; Mao W; Wang Z; Liu Z
Chem Biol Drug Des; 2024 Jun; 103(6):e14557. PubMed ID: 38825578
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
Shawky NM; Segar L
Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
[TBL] [Abstract][Full Text] [Related]
8. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer.
Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.
Yi YW; Kang HJ; Kim HJ; Hwang JS; Wang A; Bae I
Mol Carcinog; 2013 Sep; 52(9):667-75. PubMed ID: 22488590
[TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells.
Kanematsu S; Uehara N; Miki H; Yoshizawa K; Kawanaka A; Yuri T; Tsubura A
Anticancer Res; 2010 Sep; 30(9):3381-90. PubMed ID: 20944112
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells.
Wiczk A; Hofman D; Konopa G; Herman-Antosiewicz A
Biochim Biophys Acta; 2012 Aug; 1823(8):1295-305. PubMed ID: 22640870
[TBL] [Abstract][Full Text] [Related]
12. The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner.
Zhang Y; Gilmour A; Ahn YH; de la Vega L; Dinkova-Kostova AT
Phytomedicine; 2021 Jun; 86():153062. PubMed ID: 31409554
[TBL] [Abstract][Full Text] [Related]
13. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
14. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889
[TBL] [Abstract][Full Text] [Related]
15. S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer.
Nawroth R; Stellwagen F; Schulz WA; Stoehr R; Hartmann A; Krause BJ; Gschwend JE; Retz M
PLoS One; 2011; 6(11):e27509. PubMed ID: 22110663
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
Leung EY; Askarian-Amiri M; Finlay GJ; Rewcastle GW; Baguley BC
PLoS One; 2015; 10(7):e0131400. PubMed ID: 26148118
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.
Lu Z; Zhang Y; Xu Y; Wei H; Zhao W; Wang P; Li Y; Hou G
Mol Biol Rep; 2022 Jan; 49(1):451-461. PubMed ID: 34731371
[TBL] [Abstract][Full Text] [Related]
18. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
19. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]